BUZZ-CK Life hits 17-month peak on patent application for cancer vaccines

Reuters

04/11

** CK Life Sciences 0775.HK soars as much as 41.7% to HK$0.68, highest since November 2023

** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse

** Healthcare and pharma products maker files Original Grant Patent application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines

** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co

** Stock up 17.1% YTD

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2526506005"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2526506005\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2526506005?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-11 12:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2526506005","market":"us","top_or_hot":-1,"title":"BUZZ-CK Life hits 17-month peak on patent application for cancer vaccines","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-CK Life hits 17-month peak on patent application for cancer vaccines</title></head><body><p>** CK Life Sciences <span>0775.HK</span> soars as much as 41.7% to HK$0.68, highest since November 2023</p><p>** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse</p><p>** Healthcare and pharma products maker files Original Grant <span>Patent</span> application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines</p><p>** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co</p><p>** Stock up 17.1% YTD</p><p> (Reporting by Donny Kwok)</p><p> ((donny.kwok@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-CK Life hits 17-month peak on patent application for cancer vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-CK Life hits 17-month peak on patent application for cancer vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-04-11 12:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-CK Life hits 17-month peak on patent application for cancer vaccines</title></head><body><p>** CK Life Sciences <span>0775.HK</span> soars as much as 41.7% to HK$0.68, highest since November 2023</p><p>** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse</p><p>** Healthcare and pharma products maker files Original Grant <span>Patent</span> application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines</p><p>** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co</p><p>** Stock up 17.1% YTD</p><p> (Reporting by Donny Kwok)</p><p> ((donny.kwok@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00775","symbol_name":"长江生命科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nL2N3QP04E:1","article_id":"2526506005","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2526506005","pubTimestamp":1744344607,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-CK Life hits 17-month peak on patent application for cancer vaccines** CK Life Sciences 0775.HK soars as much as 41.7% to HK$0.68, highest since November 2023** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse** Healthcare and pharma products maker files Original Grant Patent application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co** Stock up 17.1% YTD  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00775":"长江生命科技","BK1161":"生物科技","BK1569":"长和系"},"translate_title":"BUZZ-CK Life癌症疫苗专利申请创17个月新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00775":0.9},"content_text":"BUZZ-CK Life hits 17-month peak on patent application for cancer vaccines** CK Life Sciences 0775.HK soars as much as 41.7% to HK$0.68, highest since November 2023** Stock on course for biggest one-day pct rise since June 2022; fourth biggest pct gainer on HK bourse** Healthcare and pharma products maker files Original Grant Patent application in Hong Kong and provisional patent application with the U.S. Patent and Trademark Office for its circular mRNA and fusion protein TROP2 cancer vaccines** Says successful commercialisation of TROP2 cancer vaccine could potentially generate significant economic benefits for co** Stock up 17.1% YTD (Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}